Sandra Milligan - 04 May 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of Research & Development
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Issuer symbol: OGN
Transactions as of: 04 May 2023
Net transactions value: -$52,552
Form type: 4
Filing time: 08 May 2023, 18:43:51 UTC
Previous filing: 03 May 2023
Next filing: 09 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+4,984	+19%		30,767	04 May 2023	Direct	F1
transaction	OGN	Common Stock	Tax liability	$52,552	-2,168	-7%	$24.24	28,599	04 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-4,984	-50%	$0.000000	4,984	04 May 2023	Common Stock	4,989		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.